666 related articles for article (PubMed ID: 29482156)
1. Berberine inhibits macrophage M1 polarization via AKT1/SOCS1/NF-κB signaling pathway to protect against DSS-induced colitis.
Liu Y; Liu X; Hua W; Wei Q; Fang X; Zhao Z; Ge C; Liu C; Chen C; Tao Y; Zhu Y
Int Immunopharmacol; 2018 Apr; 57():121-131. PubMed ID: 29482156
[TBL] [Abstract][Full Text] [Related]
2. Moluodan promotes DSS-induced intestinal inflammation involving the reprogram of macrophage function and polarization.
Zhao M; Qiao C; Cui Z; Zhang W; Yang S; Zhu C; Du F; Ning T; Xie S; Liu S; Li P; Xu J; Zhu S
J Ethnopharmacol; 2024 Feb; 320():117393. PubMed ID: 37952735
[TBL] [Abstract][Full Text] [Related]
3. Berberine induces SOCS1 pathway to reprogram the M1 polarization of macrophages via miR-155-5p in colitis-associated colorectal cancer.
Ling Q; Fang J; Zhai C; Huang W; Chen Y; Zhou T; Liu Y; Fang X
Eur J Pharmacol; 2023 Jun; 949():175724. PubMed ID: 37059377
[TBL] [Abstract][Full Text] [Related]
4. Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL/6 mice by suppressing Th17 responses.
Li YH; Xiao HT; Hu DD; Fatima S; Lin CY; Mu HX; Lee NP; Bian ZX
Pharmacol Res; 2016 Aug; 110():227-239. PubMed ID: 26969793
[TBL] [Abstract][Full Text] [Related]
5. Isomeranzin suppresses inflammation by inhibiting M1 macrophage polarization through the NF-κB and ERK pathway.
Xu G; Feng L; Song P; Xu F; Li A; Wang Y; Shen Y; Wu X; Luo Q; Wu X; Sun Y; Wu X; Xu Q
Int Immunopharmacol; 2016 Sep; 38():175-85. PubMed ID: 27285671
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory effects of Brucea javanica oil emulsion by suppressing NF-κB activation on dextran sulfate sodium-induced ulcerative colitis in mice.
Huang YF; Zhou JT; Qu C; Dou YX; Huang QH; Lin ZX; Xian YF; Xie JH; Xie YL; Lai XP; Su ZR
J Ethnopharmacol; 2017 Feb; 198():389-398. PubMed ID: 28119098
[TBL] [Abstract][Full Text] [Related]
7. Ginsenoside metabolite compound K promotes recovery of dextran sulfate sodium-induced colitis and inhibits inflammatory responses by suppressing NF-κB activation.
Li J; Zhong W; Wang W; Hu S; Yuan J; Zhang B; Hu T; Song G
PLoS One; 2014; 9(2):e87810. PubMed ID: 24504372
[TBL] [Abstract][Full Text] [Related]
8. Berberine promotes recovery of colitis and inhibits inflammatory responses in colonic macrophages and epithelial cells in DSS-treated mice.
Yan F; Wang L; Shi Y; Cao H; Liu L; Washington MK; Chaturvedi R; Israel DA; Cao H; Wang B; Peek RM; Wilson KT; Polk DB
Am J Physiol Gastrointest Liver Physiol; 2012 Mar; 302(5):G504-14. PubMed ID: 22173918
[TBL] [Abstract][Full Text] [Related]
9. Oroxyloside prevents dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB pathway through PPARγ activation.
Wang X; Sun Y; Zhao Y; Ding Y; Zhang X; Kong L; Li Z; Guo Q; Zhao L
Biochem Pharmacol; 2016 Apr; 106():70-81. PubMed ID: 26947454
[TBL] [Abstract][Full Text] [Related]
10. Sodium butyrate inhibits the NF-kappa B signaling pathway and histone deacetylation, and attenuates experimental colitis in an IL-10 independent manner.
Lee C; Kim BG; Kim JH; Chun J; Im JP; Kim JS
Int Immunopharmacol; 2017 Oct; 51():47-56. PubMed ID: 28802151
[TBL] [Abstract][Full Text] [Related]
11. Cinobufacini Ameliorates Dextran Sulfate Sodium-Induced Colitis in Mice through Inhibiting M1 Macrophage Polarization.
Wang SW; Bai YF; Weng YY; Fan XY; Huang H; Zheng F; Xu Y; Zhang F
J Pharmacol Exp Ther; 2019 Mar; 368(3):391-400. PubMed ID: 30606760
[TBL] [Abstract][Full Text] [Related]
12. Dihydroartemisinin Protects against Dextran Sulfate Sodium-Induced Colitis in Mice through Inhibiting the PI3K/AKT and NF-
Li N; Sun W; Zhou X; Gong H; Chen Y; Chen D; Xiang F
Biomed Res Int; 2019; 2019():1415809. PubMed ID: 31781591
[TBL] [Abstract][Full Text] [Related]
13. Convallatoxin protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB signaling through activation of PPARγ.
Li MY; Zhang ZH; Wang Z; Zuo HX; Wang JY; Xing Y; Jin CH; Xu GH; Piao LX; Ma J; Jin X
Pharmacol Res; 2019 Sep; 147():104355. PubMed ID: 31386886
[TBL] [Abstract][Full Text] [Related]
14. Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway.
Li C; Ai G; Wang Y; Lu Q; Luo C; Tan L; Lin G; Liu Y; Li Y; Zeng H; Chen J; Lin Z; Xian Y; Huang X; Xie J; Su Z
Pharmacol Res; 2020 Feb; 152():104603. PubMed ID: 31863867
[TBL] [Abstract][Full Text] [Related]
15. Ursolic acid inhibits nuclear factor-κB signaling in intestinal epithelial cells and macrophages, and attenuates experimental colitis in mice.
Chun J; Lee C; Hwang SW; Im JP; Kim JS
Life Sci; 2014 Aug; 110(1):23-34. PubMed ID: 24992474
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory effects of Platycodin D on dextran sulfate sodium (DSS) induced colitis and E. coli Lipopolysaccharide (LPS) induced inflammation.
Guo R; Meng Q; Wang B; Li F
Int Immunopharmacol; 2021 May; 94():107474. PubMed ID: 33611056
[TBL] [Abstract][Full Text] [Related]
17. Limonin ameliorates dextran sulfate sodium-induced chronic colitis in mice by inhibiting PERK-ATF4-CHOP pathway of ER stress and NF-κB signaling.
Song C; Chen J; Li X; Yang R; Cao X; Zhou L; Zhou Y; Ying H; Zhang Q; Sun Y
Int Immunopharmacol; 2021 Jan; 90():107161. PubMed ID: 33168409
[TBL] [Abstract][Full Text] [Related]
18. Demethyleneberberine alleviates inflammatory bowel disease in mice through regulating NF-κB signaling and T-helper cell homeostasis.
Chen YY; Li RY; Shi MJ; Zhao YX; Yan Y; Xu XX; Zhang M; Zhao XT; Zhang YB
Inflamm Res; 2017 Feb; 66(2):187-196. PubMed ID: 27900412
[TBL] [Abstract][Full Text] [Related]
19. Fisetin, a dietary flavonoid, ameliorates experimental colitis in mice: Relevance of NF-κB signaling.
Sahu BD; Kumar JM; Sistla R
J Nutr Biochem; 2016 Feb; 28():171-82. PubMed ID: 26878795
[TBL] [Abstract][Full Text] [Related]
20. Artemisinin analogue SM934 ameliorates DSS-induced mouse ulcerative colitis via suppressing neutrophils and macrophages.
Yan YX; Shao MJ; Qi Q; Xu YS; Yang XQ; Zhu FH; He SJ; He PL; Feng CL; Wu YW; Li H; Tang W; Zuo JP
Acta Pharmacol Sin; 2018 Oct; 39(10):1633-1644. PubMed ID: 29849131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
